Epidemiology and risk factors for hepatitis C in Alaska Natives
- PMID: 14767985
- DOI: 10.1002/hep.20046
Epidemiology and risk factors for hepatitis C in Alaska Natives
Abstract
Large cohorts of persons infected with hepatitis C virus (HCV) that include patients with multiple risk exposures and behaviors have been rarely reported. We herein describe a population-based cohort of 759 Alaska Natives (AN) with HCV who were recruited into a long-term follow-up study. History of injection drug use (IDU) was reported by 60.1% and blood transfusion by 14.0%. The most common genotype was 1a (42.0%), followed by 1b (20.3%), 2b (14.7%), 3a (14.3%), and 2a (7.8%). By multivariable analysis, risk exposures (blood transfusion vs. other; P < 0.01; odds ratio [OR], 2.87; 95% confidence interval [CI], 1.51-5.45) and year of infection (P < 0.01; OR, 3.47; 95% CI, 1.34-8.96) were significantly associated with HCV RNA-positivity. Having an RNA concentration >/=2 million copies/mL was associated with male gender (OR, 1.94) and genotype (P < 0.01 overall; 1a vs. 3a: OR, 1.92; 2b vs. 3a: OR, 3.17) by multivariable analysis. In conclusion, the two principal risk exposures for AN infected with HCV (IDU and blood transfusion) are the same as the overall U.S. population. Persons with a history of blood transfusion were more likely to be HCV RNA positive than those without such history. Higher RNA levels found in males may explain the more severe disease previously reported in this group.
Similar articles
-
Molecular epidemiology of hepatitis C infection in U.S. veteran liver transplant recipients: evidence for decreasing relative prevalence of genotype 1B.Am J Gastroenterol. 1999 Oct;94(10):3015-9. doi: 10.1111/j.1572-0241.1999.01456.x. Am J Gastroenterol. 1999. PMID: 10520862
-
Adverse outcomes in Alaska natives who recovered from or have chronic hepatitis C infection.Gastroenterology. 2010 Mar;138(3):922-31.e1. doi: 10.1053/j.gastro.2009.10.056. Epub 2009 Nov 10. Gastroenterology. 2010. PMID: 19909749
-
Prevalence of chronic hepatitis C virus genotypes among patients between 21 to 65 years old in Puerto Rico.P R Health Sci J. 2004 Jun;23(2 Suppl):49-56. P R Health Sci J. 2004. PMID: 16929587
-
Hepatitis C infection in Alaska Natives with persistently normal, persistently elevated or fluctuating alanine aminotransferase levels.Liver Int. 2006 Aug;26(6):643-9. doi: 10.1111/j.1478-3231.2006.01281.x. Liver Int. 2006. PMID: 16842319
-
Hepatitis C virus genotypes and viral concentrations in participants of a general population survey in the United States.Gastroenterology. 2006 Aug;131(2):478-84. doi: 10.1053/j.gastro.2006.06.007. Gastroenterology. 2006. PMID: 16890602
Cited by
-
Factors associated with hepatitis C virus RNA levels in early chronic infection: the InC3 study.J Viral Hepat. 2015 Sep;22(9):708-17. doi: 10.1111/jvh.12384. Epub 2015 Jan 8. J Viral Hepat. 2015. PMID: 25580520 Free PMC article.
-
Risk of end-stage liver disease, hepatocellular carcinoma, and liver-related death by fibrosis stage in the hepatitis C Alaska Cohort.Hepatology. 2017 Jul;66(1):37-45. doi: 10.1002/hep.29115. Epub 2017 May 22. Hepatology. 2017. PMID: 28195349 Free PMC article.
-
Hepatitis C virus envelope glycoprotein co-evolutionary dynamics during chronic hepatitis C.Virology. 2008 Jun 5;375(2):580-91. doi: 10.1016/j.virol.2008.02.012. Epub 2008 Mar 17. Virology. 2008. PMID: 18343477 Free PMC article.
-
Treatment eligibility in Alaska Native and American Indian persons with hepatitis C virus infection.Int J Circumpolar Health. 2012 Apr 24;71:1-7. doi: 10.3402/ijch.v71i0.18445. Int J Circumpolar Health. 2012. PMID: 22564468 Free PMC article.
-
Infection With Hepatitis C Virus Genotype 3 Is an Independent Risk Factor for End-Stage Liver Disease, Hepatocellular Carcinoma, and Liver-Related Death.Clin Gastroenterol Hepatol. 2017 Mar;15(3):431-437.e2. doi: 10.1016/j.cgh.2016.10.012. Epub 2016 Oct 17. Clin Gastroenterol Hepatol. 2017. PMID: 27765729 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources